Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Observational × Hypoxic Tumours × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 1991 Neoplasms 1807 Lung Neoplasms 966 Colorectal Neoplasms 915 Prostatic Neoplasms 803 Carcinoma, Non-Small-Cell Lung 659 Carcinoma, Hepatocellular 598 Stomach Neoplasms 534 Pancreatic Neoplasms 524 Head and Neck Neoplasms 387 Ovarian Neoplasms 381 Colonic Neoplasms 376 Rectal Neoplasms 365 Uterine Cervical Neoplasms 351 Esophageal Neoplasms 313 Brain Neoplasms 298 Neoplasm Metastasis 285 Melanoma 274 Multiple Myeloma 272 Precursor Cell Lymphoblastic Leukemia-Lymphoma 260 Urinary Bladder Neoplasms 254 Leukemia, Myeloid, Acute 239 Lymphoma 236 Hematologic Neoplasms 225 Liver Neoplasms 224 Endometrial Neoplasms 216 Disease 204 Glioma 197 Recurrence 195 Carcinoma, Renal Cell 194

Interventions

fluoroazomycin arabinoside 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00756691 2017-11-14

A Radiopharmacokinetic and Radiodosimetric Phase I Imaging Study of 18F-FAZA

AHS Cancer Control Alberta

Hypoxic Tumours

Data powered by HemOnc (CC BY 4.0) Colophon ⚡